Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOL, looks like it was written or tweeted by Trump.
Peer reviewed? Would you please direct us to those journals? Thanks.
Yes, I worked for one of those European companies you mentioned , added some of my vacation days, and always took the last two weeks of December off.A few times I even took the last three weeks as vacation.
Yes, we have seen that many times here. Has something changed to see it Again?
Thanks Ike for all the time and effort you devoted to this. As a thank you I clicked the "follow you" tab and hope others will also.
The issuance of stock by biotechnology companies is now dominated by a few investment banking firms and in many cases the primary investors are hedge funds who specialize in biotechnology. The smaller the biotech company, the more the investor base is made up of such hedge funds. For those of you who have followed my work, you know that I believe that there are a group of hedge funds, which I call the wolfpack, that routinely manipulate the price of biotechnology stocks in the secondary market using coordinated legal shorting, illegal naked shorting, algorithmic computer trading and negative propaganda from “paid for” social media bloggers. Again, this activity is directly related to the size of the company, the smaller being most victimized. I believe that this is one of the biggest criminal enterprises in the US and tragically is carried on by certain household name investment banks and hedge funds.
www.smithonstocks.com
Is it possible Pfizer could pay around $15 Billion?
Yes, we've heard that several times.
HUGE!!!!! BS lies. How old is this BS PR? Where is the date that was on it when it was first published?
Ike, I very much appreciate the time and input you devoted to this message list so my reward to you is a member mark.
Interesting, thanks. I'm surprised SP is not higher though.
I also popped in here for the same reason. Quickly scanning the intro leaves me with a big question. It says lead Phase 3 candidate Eravracycline was being submitted for U.S. Regulatory approval in 2015. So, where is the update? Have they not updated their website/ board intro the last 4-5 years or was the submission not accepted?
This is a strange acquisition IMO. LOXO "has a collaboration with Bayer ", a major big Pharma company, but Lilly acquires LOXO. Where does that leave Bayer in this scenario? Am I missing something here?
Ok, thanks.
My first visit to this board. So, what news are you posters "wishing for"? Thanks.
Yes, the criminal locusts will be back sooner than my last prediction. SEC.gov here they come.
Stockbuilder Thursday, 11/01/18 06:10:17 PM
Re: Stockbuilder post# 40212 0
Post #
41061
of 43353
Gosh, it hasn't even been 7 weeks this time before they swarmed back, lol.
Looks like you have been around here as long as I have and seen the illegal "locusts", not the 7-year kind, but the ones that swarm in about every 7 months, lol. I usually swat them to the SEC for extermination, lol.
Could this possibly be a $15 billion deal like P was?
So, are you posting this as new news?
Correct, and criminal manipulators at that who have been reported to SEC.
Gosh, it hasn't even been 7 weeks this time before they swarmed back, lol.
Looks like you have been around here as long as I have and seen the illegal "locusts", not the 7-year kind, but the ones that swarm in about every 7 months, lol. I usually swat them to the SEC for extermination, lol.
Most are gone, either scared or fed up huh,lol?
Did they all fly away to return in 7 months,lol?
Stockbuilder Wednesday, 09/26/18 05:18:15 PM
Re: Learjetter post# 40205 0
Post #
40212
of 40905
Looks like you have been around here as long as I have and seen the illegal "locusts" , not the 7 year kind, but the ones that swarm in about every 7 months,lol. I usually swat them to the SEC for extermination,lol.
You should send that info to the SEC.
Check here, they will tell you: https://www.sec.gov/tcr
Big talkers become weak talkers when these people knock on the door,lol: https://www.sec.gov/tcr
This is the swat team pal: https://www.sec.gov/tcr
Looks like you have been around here as long as I have and seen the illegal "locusts" , not the 7 year kind, but the ones that swarm in about every 7 months,lol. I usually swat them to the SEC for extermination,lol.
Yes, looks like the illegal organized P&D gang has arrived again.
I forwarded your post to the SEC requesting more information.
Has anyone filed a complaint to the SEC or FBI?
Does Adam Feuerstein of The Street distort the truth?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=141848970
Spine Injury Solutions Announces Quad Video HALO in an upcoming national PBS TV segment
GlobeNewswire•June 19, 2018
HOUSTON, June 19, 2018 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (SPIN), a technology-driven, medical service, financing and healthcare solution company announces that “The American Health Journal,” (AHJ) the oldest and longest continuous running healthcare television program in the United States has elected to include SPIN’s QVH in a upcoming “Innovations in Medicine” segment.
"At American Health Journal, on PBS, we're always on the search for medical innovation, transformation and disruption as told by top doctors," says AHJ Global Executive Producer, Michael Lesner. "Dr. Donovan provided us with a patient-centric preview of a new video technology, one that makes high risk medical procedures safer and more effective. He has given us a look into the future for improving spinal injury management."
“We are very proud of the fact that PBS offered us the forum to display just how innovative our Quad Video Halo (QVH) product is to both the spinal injury and chronic pain market. This segment gives the viewer the real benefits that the QVH has to offer such as: helping to make higher risk medical procedures safer and more effective, helping to improve spinal injury care, helping to set a new standard for documentation of injury care procedures, helping to mitigate and reduce insurance fraud, helping to improve the ability to train and provide quality control to the doctors that do higher risk medical procedures, and helping to improve the results in the general pain care market,” said Dr. William Donovan.
Please see www.quadvideohalo.com to view the segment. (As explained further on, due to the “syndicated” status of Innovations in Medicine segment, each market and multiple release times are different so management decided to give you the QVH website.)
In the US according to the Center for Disease Control there are over 39 million injuries a year, which means every day in America over 108,000 people are injured. This leads to over 115,000 Emergency Room visits, and over 252,000 medical visits a day for these injuries. We know that this market needs help and we know that our QVH technology can be a major contribution. You can see our PBS segment with the link below.
As to PBS, well here is a little more about our video host.
Winning over 100 National and International awards since 1988 and with a current reach of 118 million viewers and 46 million households "American Health Journal" public television program has been dedicated to informing the public on prevention, treatments, research and the latest advancements in medicine.
American Health Journal on PBS, is a “Syndicated” show as compared to a “Network Show.” For that reason, this show will air multiple and different time in different PBS markets at the discretion of the local PBS stations. Shortly prior to its imminent release, you should find a listing and time slot in your local “TV Guide” if your city is one of the over 400 which airs American Health Journal beginning this week. However, due to the randomness of release to all of these stations, the Company has approved the direct link to the SPIN QVH segment on the QVH website.
As compared to a Network Show, which would likely air a show only once or twice a year, according to AHJ, a PBS syndicated show will likely average three times in a day for several weeks. Once released, the show will also be available for retrieval on the AHJ channel of Youtube.com.
Dr. Donovan stated; “We are proud to be included in 'Innovations in Medicine' segment of the highly respected American Health Journal. AHJ has been recognized as the top recurring medical show known to the vast majority of Doctors and other medical professionals. To have this recognition of the QVH and its benefits, in addition to vastly increasing the exposure of the QVH to the medical profession, it will increase credibility of the QVH.”
George,
Thanks. Evidently you like to play games, or perhaps you use a different calendar?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139703656
CTIX closed at ~1.08 at the time of this quote
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=128559740
I haven't been reading the board lately so what were the results of those predictions? Thanks.
Speaking of incompetence, this crew of clowns who are supposedly hashing out this arbitration case are the most incompetent gang of circus clowns I have seen in all my past 30+ years of playing with stocks.
Spine Injury Solutions Announces Results for the Fiscal First Quarter Ended March 31, 2018
12:24 pm ET May 14, 2018 (Globe Newswire) Print
Spine Injury Solutions, Inc. (OTCQB:SPIN), today announced financial results for its Fiscal 2018 first quarter ended March 31, 2018.
Financial Highlights
-- Revenues for the quarter ended March 31, 2018 increased 26% to $634,426, as compared to $501,163 during the same period the prior year.
-- Gross Profit increased 28% to $440,781, as compared to $344,359 during the same period the prior year.
-- Net income was $90,305, as compared to a loss of $49,389 for same period the prior year.
Dr. William Donovan, Chairman and Chief Executive Officer commented, "I am pleased to announce the first quarter was a period filled with opportunities for us due to our aggressive sales and marketing efforts we implemented in 2017. Throughout the quarter our affiliate programs continued to garner what we believe is increasing interest from our unique services. We continued to introduce our Quad Video Halo to our target markets and through these efforts we've been focusing on numerous applications to enhance our knowledge of the challenges encountered in these markets that require innovative solutions where the Quad Video Halo can play a central role. We continue to incorporate this input to ensure that we are meeting the specific needs of market applications in the most flexible manner."
Results of Operations
For the Quarter ended March 31, 2018.
Comparison of the three month period ended March 31, 2018 with the three month period ended March 31, 2017.
We recorded $1,058,124 in gross revenue for the three months ended March 31, 2018, offset by $423,698 of the variable consideration discount resulting in net revenue of $634,426. For the same period in 2017, gross revenue was $831,320, offset by $330,157 of the variable consideration discount, resulting in net revenue of $501,163. For the three months ended March 31, 2018, we worked with four spine injury diagnostic centers: Houston, Texas; Tyler, Texas; Odessa, Texas and Las Cruces, New Mexico. Service cost was $193,645 for the three months ended March 31, 2018 compared to $156,804 for the same period in 2017. The increase in service cost is attributable to the higher case volume in Odessa, coupled with our Las Cruces affiliate recording revenue for the first time in the first quarter of 2018.
During the three months ended March 31, 2018, we incurred $349,273 of operating, general and administrative expenses compared to $382,028 for the same period in 2017. Operating, general and administrative expenses were lower or the 2018 quarter compared to 2017 primarily because of a decrease in consulting fees, website planning expense and payroll expenses, website planning fees, and traveling expenses totaling approximately $48,000, coupled with increases in bad debt expense, travel expense, rent, legal expenses and other expenses of $15,000. The higher consulting costs for the quarter ended March 31, 2017 were mostly incurred in connection with the marketing of the QVH. There were no research and development costs during the quarter ended March 31, 2017. We also experienced an increase of $8,081 in non-cash operating charges from $46,827 for the three months ended March 31, 2017 to $54,908 for the three months ended March 31, 2018.
As a result of the foregoing, we had net profit of $90,305 for the three months ended March 31, 2018, compared to a net loss of $49,389 for the three months ended March 31, 2017.
Liquidity and Capital Resources
For the three months ended March 31, 2018, cash provided in operations was $5,068 which primarily included increases in accounts receivable of $74,201, increase of inventory of $15,782 and increases in prepaid expenses of $27,750, related party payables of $18,222 and accounts payable of $4,190. For the same period in 2017 cash used in operations was $93,553 which primarily included decreases in accounts receivable of $4,080 and increases in prepaid expenses of $27,750, related party payables of $44,066 and accounts payable of $23,255. We used no cash in investing activities for the three months ended March 31, 2018 and 2017.
Cash used in financing activities for the three months ended March 31, 2018 and 2017 consisted of repayments on our notes payable in the amount of $25,000 and $50,000, to two separate parties respectively. We collected $560,343 and $419,086 in settlements during the three months ended March 31, 2018 and 2017, respectively.
Conclusion
Dr. Donovan concluded, "We remain committed to developing long-term partnerships, increasing revenues, generating positive cash flow and remaining profitable. We are focused on establishing new strategic relationships, as well as pursuing unique opportunities with our current partners and potential affiliates. Our emphasis for the remainder of the fiscal year will be on maximizing our sales and marketing activities as well as improving overall operational execution."
Conference Call Details
Conference Call: An investor's conference call with management will be held today, Monday, May 14, at 4:20 p.m. (EDT).
Conference Dial-in Number: 1 (415) 655-0052
Participant Access Code: 709-048-440
Click or paste the link below in your browser for registration and web access to the presentation and follow the online instructions:
Registration URL: https://attendee.gotowebinar.com/register/5210283628958749954
Webinar ID: 248-735-515
Access to the Call: To use the internet link, you must register prior to access. It is suggested you complete the registration and get your log-in information in advance of the start of the presentation. You can register at any time. Questions can be typed into an online chat screen at any time during the presentation or Q & A period.
The Q & A will be moderated, but without an operator, and will be open to all questions after the formal presentations.
Conference Play Back: A video replay of the conference call presentation will be available at the company website: http://www.SpineInjurySolutions.com
About Spine Injury Solutions, Inc:
We are a medical services and technology company facilitating diagnostic services for patients who have sustained spine injuries resulting from traumatic accidents. We deliver turnkey solutions to spine surgeons, orthopedic surgeons and other healthcare providers that provide necessary and appropriate treatment of musculo-skeletal spine injuries resulting from automobile and work-related accidents. Our technology and funding services help reduce the financial burden on healthcare providers that provide patients with early-stage diagnostic testing and non-invasive surgical care, preventing many patients from being unnecessarily delayed or inhibited from obtaining needed treatment. We believe that our services and technology brings strong transparency and impartiality to all parties involved in the settlement of patient cases.
Additional information about the company, along with a video replay of most recent Investor Conference Call can be found at its website at www.spineinjurysolutions.com.
About Quad Video HALO, Inc.:
A wholly owned subsidiary of Spine Injury Solutions, Inc. Quad Video HALO, Inc. brings surgeons and interventional pain doctors the technology to provide Transparency of their surgical procedures. The Quad Video Technology V3.0 and HALO Rx creates a digital turnkey video and audio documentation solutions that integrates multiple views from other OR/treatment imagining sources with several other viewpoints just outside the sterile field.
Additional information about QVH, can be found at its website at www.QuadVideoHalo.com
Forward-Looking Statements: This press release includes forward-looking statements as determined by the U.S. Securities and Exchange Commission (the "SEC"). All statements, other than statements of historical facts, included in this press release that address activities, events, or developments that the company believes or anticipates will or may occur in the future are forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to acquire and develop specific projects, the ability to fund operations, healthcare services demands, changes in healthcare practices, government regulation, and other factors over which the company has little or no control. The company does not intend (and is not obligated) to update publicly any forward-looking statements. The contents of this press release should be considered in conjunction with the warnings and cautionary statements contained in the company's recent filings with the SEC.
Investor Relations Contact:
Andrew Barwicki
Phone: 516-662-9461
Email: Andrew@barwicki.com
Spine Injury Solutions Announces Results for the Fiscal First Quarter Ended March 31, 2018
12:24 pm ET May 14, 2018 (Globe Newswire) Print
Spine Injury Solutions, Inc. (OTCQB:SPIN), today announced financial results for its Fiscal 2018 first quarter ended March 31, 2018.
Financial Highlights
-- Revenues for the quarter ended March 31, 2018 increased 26% to $634,426, as compared to $501,163 during the same period the prior year.
-- Gross Profit increased 28% to $440,781, as compared to $344,359 during the same period the prior year.
-- Net income was $90,305, as compared to a loss of $49,389 for same period the prior year.
Dr. William Donovan, Chairman and Chief Executive Officer commented, "I am pleased to announce the first quarter was a period filled with opportunities for us due to our aggressive sales and marketing efforts we implemented in 2017. Throughout the quarter our affiliate programs continued to garner what we believe is increasing interest from our unique services. We continued to introduce our Quad Video Halo to our target markets and through these efforts we've been focusing on numerous applications to enhance our knowledge of the challenges encountered in these markets that require innovative solutions where the Quad Video Halo can play a central role. We continue to incorporate this input to ensure that we are meeting the specific needs of market applications in the most flexible manner."
Results of Operations
For the Quarter ended March 31, 2018.
Comparison of the three month period ended March 31, 2018 with the three month period ended March 31, 2017.
We recorded $1,058,124 in gross revenue for the three months ended March 31, 2018, offset by $423,698 of the variable consideration discount resulting in net revenue of $634,426. For the same period in 2017, gross revenue was $831,320, offset by $330,157 of the variable consideration discount, resulting in net revenue of $501,163. For the three months ended March 31, 2018, we worked with four spine injury diagnostic centers: Houston, Texas; Tyler, Texas; Odessa, Texas and Las Cruces, New Mexico. Service cost was $193,645 for the three months ended March 31, 2018 compared to $156,804 for the same period in 2017. The increase in service cost is attributable to the higher case volume in Odessa, coupled with our Las Cruces affiliate recording revenue for the first time in the first quarter of 2018.
During the three months ended March 31, 2018, we incurred $349,273 of operating, general and administrative expenses compared to $382,028 for the same period in 2017. Operating, general and administrative expenses were lower or the 2018 quarter compared to 2017 primarily because of a decrease in consulting fees, website planning expense and payroll expenses, website planning fees, and traveling expenses totaling approximately $48,000, coupled with increases in bad debt expense, travel expense, rent, legal expenses and other expenses of $15,000. The higher consulting costs for the quarter ended March 31, 2017 were mostly incurred in connection with the marketing of the QVH. There were no research and development costs during the quarter ended March 31, 2017. We also experienced an increase of $8,081 in non-cash operating charges from $46,827 for the three months ended March 31, 2017 to $54,908 for the three months ended March 31, 2018.
As a result of the foregoing, we had net profit of $90,305 for the three months ended March 31, 2018, compared to a net loss of $49,389 for the three months ended March 31, 2017.
Liquidity and Capital Resources
For the three months ended March 31, 2018, cash provided in operations was $5,068 which primarily included increases in accounts receivable of $74,201, increase of inventory of $15,782 and increases in prepaid expenses of $27,750, related party payables of $18,222 and accounts payable of $4,190. For the same period in 2017 cash used in operations was $93,553 which primarily included decreases in accounts receivable of $4,080 and increases in prepaid expenses of $27,750, related party payables of $44,066 and accounts payable of $23,255. We used no cash in investing activities for the three months ended March 31, 2018 and 2017.
Cash used in financing activities for the three months ended March 31, 2018 and 2017 consisted of repayments on our notes payable in the amount of $25,000 and $50,000, to two separate parties respectively. We collected $560,343 and $419,086 in settlements during the three months ended March 31, 2018 and 2017, respectively.
Conclusion
Dr. Donovan concluded, "We remain committed to developing long-term partnerships, increasing revenues, generating positive cash flow and remaining profitable. We are focused on establishing new strategic relationships, as well as pursuing unique opportunities with our current partners and potential affiliates. Our emphasis for the remainder of the fiscal year will be on maximizing our sales and marketing activities as well as improving overall operational execution."
Has anyone filed a complaint against them with the SEC? Some law group out there would probably like to do that.
I haven't been keeping up with the board much so what is the latest?
Expect the Prurisol Phase 2b trial data to be unblinded by or before Monday April 2, 2018 and the Prurisol Phase 2b trial topline resluts to be released by or before Monday April 16, 2018.
Sorry to bring this up again but I was posting about those "flying" videos connected to the story/article. For instance article about a police car chase and while trying to read the print part the blasted video of the actual chase "flies" down to bottom right partially obscuring the printed article. I think your answers to me were for ads which adblock will block but will not the moving videos.
If this makes any sense I would appreciate some help here. TIA.